关注
Alvaro Quintanal-Villalonga
Alvaro Quintanal-Villalonga
在 mskcc.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
The human tumor atlas network: charting tumor transitions across space and time at single-cell resolution
O Rozenblatt-Rosen, A Regev, P Oberdoerffer, T Nawy, A Hupalowska, ...
Cell 181 (2), 236-249, 2020
3972020
Lineage plasticity in cancer: a shared pathway of therapeutic resistance
Á Quintanal-Villalonga, JM Chan, HA Yu, D Pe’er, CL Sawyers, T Sen, ...
Nature reviews Clinical oncology 17 (6), 360-371, 2020
3322020
Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes
M Offin, JM Chan, M Tenet, HA Rizvi, R Shen, GJ Riely, N Rekhtman, ...
Journal of Thoracic Oncology 14 (10), 1784-1793, 2019
2752019
Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer
JM Chan, A Quintanal-Villalonga, VR Gao, Y Xie, V Allaj, O Chaudhary, ...
Cancer cell 39 (11), 1479-1496. e18, 2021
2022021
Concurrent mutations in STK11 and KEAP1 promote ferroptosis protection and SCD1 dependence in lung cancer
CA Wohlhieter, AL Richards, F Uddin, CH Hulton, À Quintanal-Villalonga, ...
Cell reports 33 (9), 2020
1432020
Multiomic analysis of lung tumors defines pathways activated in neuroendocrine transformation
A Quintanal-Villalonga, H Taniguchi, YA Zhan, MM Hasan, SS Chavan, ...
Cancer discovery 11 (12), 3028-3047, 2021
832021
FGFR1 cooperates with EGFR in lung cancer oncogenesis, and their combined inhibition shows improved efficacy
A Quintanal-Villalonga, S Molina-Pinelo, C Cirauqui, L Ojeda-Márquez, ...
Journal of Thoracic Oncology 14 (4), 641-655, 2019
572019
Epigenetics of lung cancer: a translational perspective
Á Quintanal-Villalonga, S Molina-Pinelo
Cellular Oncology 42 (6), 739-756, 2019
522019
Targeting lysine-specific demethylase 1 rescues major histocompatibility complex class I antigen presentation and overcomes programmed death-ligand 1 blockade resistance in SCLC
EM Nguyen, H Taniguchi, JM Chan, YA Zhan, X Chen, J Qiu, ...
Journal of Thoracic Oncology 17 (8), 1014-1031, 2022
432022
The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer
A Chow, FZ Uddin, M Liu, A Dobrin, BY Nabet, L Mangarin, Y Lavin, ...
Immunity 56 (1), 93-106. e6, 2023
382023
Multiple Vibrio fischeri genes are involved in biofilm formation and host colonization
A Chavez-Dozal, D Hogan, C Gorman, A Quintanal-Villalonga, ...
FEMS microbiology ecology 81 (3), 562-573, 2012
352012
Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation
A Quintanal-Villalonga, H Taniguchi, YA Zhan, MM Hasan, SS Chavan, ...
Journal of Hematology & Oncology 14, 1-19, 2021
342021
Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade
JA Pai, MD Hellmann, JL Sauter, M Mattar, H Rizvi, HJ Woo, N Shah, ...
Cancer Cell 41 (4), 776-790. e7, 2023
322023
Rb tumor suppressor in small cell lung cancer: combined genomic and IHC analysis with a description of a distinct Rb-proficient subset
CA Febres-Aldana, JC Chang, R Ptashkin, Y Wang, E Gedvilaite, ...
Clinical Cancer Research 28 (21), 4702-4713, 2022
322022
Direct genome editing of patient-derived xenografts using CRISPR-Cas9 enables rapid in vivo functional genomics
CH Hulton, EA Costa, NS Shah, A Quintanal-Villalonga, G Heller, ...
Nature cancer 1 (3), 359-369, 2020
322020
The FGFR4-388arg variant promotes lung cancer progression by N-cadherin induction
Á Quintanal-Villalonga, L Ojeda-Márquez, Á Marrugal, P Yagüe, ...
Scientific reports 8 (1), 2394, 2018
322018
Rlf–Mycl Gene Fusion Drives Tumorigenesis and Metastasis in a Mouse Model of Small Cell Lung Cancer
M Ciampricotti, T Karakousi, AL Richards, À Quintanal-Villalonga, ...
Cancer discovery 11 (12), 3214-3229, 2021
262021
Inhibition of XPO1 sensitizes small cell lung cancer to first-and second-line chemotherapy
A Quintanal-Villalonga, H Taniguchi, Y Hao, A Chow, YA Zhan, ...
Cancer research 82 (3), 472-483, 2022
252022
MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma
I Ferrer, Á Quintanal-Villalonga, S Molina-Pinelo, JM Garcia-Heredia, ...
Journal of Experimental & Clinical Cancer Research 37, 1-13, 2018
242018
IL-11 and CCL-1: novel protein diagnostic biomarkers of lung adenocarcinoma in bronchoalveolar lavage fluid (BALF)
MD Pastor, A Nogal, S Molina-Pinelo, A Quintanal-Villalonga, ...
Journal of Thoracic Oncology 11 (12), 2183-2192, 2016
212016
系统目前无法执行此操作,请稍后再试。
文章 1–20